BIOPSYPEN

OPTICAL BIOPSY PEN: A COMPACT AND LOW-COST DIAGNOSTIC TOOL FOR DERMATOLOGY BASED ON HIGH-PERFORMING INTEGRATED OCT

 Coordinatore MEDLUMICS 

 Organization address address: RONDA DE PONIENTE 16-1E
city: TRES CANTOS
postcode: 28760

contact info
Titolo: Dr.
Nome: Jose Luis
Cognome: Rubio
Email: send email
Telefono: 34918033925
Fax: 34918049321

 Nazionalità Coordinatore Spain [ES]
 Totale costo 4˙666˙979 €
 EC contributo 3˙600˙000 €
 Programma FP7-ICT
Specific Programme "Cooperation": Information and communication technologies
 Code Call FP7-ICT-2013-10
 Funding Scheme CP
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-10-01   -   2016-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    MEDLUMICS

 Organization address address: RONDA DE PONIENTE 16-1E
city: TRES CANTOS
postcode: 28760

contact info
Titolo: Dr.
Nome: Jose Luis
Cognome: Rubio
Email: send email
Telefono: 34918033925
Fax: 34918049321

ES (TRES CANTOS) coordinator 0.00
2    EXALOS AG

 Organization address address: WAGISTRASSE
city: SCHLIEREN
postcode: 8952

contact info
Titolo: Dr.
Nome: Christian
Cognome: Velez
Email: send email
Telefono: +41 434446092

CH (SCHLIEREN) participant 0.00
3    MEDIZINISCHE UNIVERSITAET WIEN

 Organization address address: SPITALGASSE
city: WIEN
postcode: 1090

contact info
Titolo: Dr.
Nome: Wolfgang
Cognome: Drexler
Email: send email
Telefono: +0043 1404001986

AT (WIEN) participant 0.00
4    Optocap Ltd

 Organization address address: Bain Square
city: Livingston
postcode: EH54 7DQ

contact info
Titolo: Mr.
Nome: Stephen
Cognome: Duffy
Email: send email
Telefono: +44 1506403550

UK (Livingston) participant 0.00
5    TECHNISCHE UNIVERSITEIT DELFT

 Organization address address: Stevinweg
city: DELFT
postcode: 2628 CN

contact info
Titolo: Prof.
Nome: Lina
Cognome: Sarro
Email: send email
Telefono: +31 152787708

NL (DELFT) participant 0.00
6    TEKNOLOGIAN TUTKIMUSKESKUS VTT

 Organization address address: TEKNIIKANTIE
city: ESPOO
postcode: 02044 VTT

contact info
Titolo: Dr.
Nome: Timo
Cognome: Aalto
Email: send email
Telefono: +358 207226694

FI (ESPOO) participant 0.00
7    UNIVERSIDAD POLITECNICA DE MADRID

 Organization address address: CALLE RAMIRO DE MAEZTU
city: MADRID
postcode: 28040

contact info
Titolo: Prof.
Nome: Roberto
Cognome: PRIETO
Email: send email
Telefono: +34 913366048
Fax: +34 913365974

ES (MADRID) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

optical    complementary    biopsypen    size    nbiopsypen    skin    point    instrumentation    optics    adoption    reduce    compact    oct    visualization    clinical    significantly    handheld    cancer    combination    care    diagnosis    maintenance   

 Obiettivo del progetto (Objective)

Optical coherence tomography (OCT) is an emerging optical diagnosis that enables in vivo tomographic visualization for non-invasive optical biopsy. OCT has proven its value primarily in ophthalmology, but recently also in dermatology. However, wide adoption has not taken place due to size and cost limitations as well as non-existence of handheld devices.nHence BIOPSYPEN will develop a new OCT generation with step-changes in size and cost beyond state-of-the-art to radically transform OCT instrumentation for handheld point-of-care diagnosis. In contrast to conventional approaches, BIOPSYPEN's OCT is based on integrated optics, more precisely on hybrid integration of silicon photonics with III-V sources, enabling a significantly smaller, low-cost, compact and maintenance free alternative.nBIOPSYPEN will target complementary research to develop an unprecedented compact (pencil-like), reliable, low-cost, battery-operated, wireless handheld OCT device in combination with an embedded system based external console to receive two-and three-dimensional tomograms for instantaneous post processing and visualization as well as immediate diagnosis.nBIOPSYPEN will contribute to a significantly wider adoption of OCT in real clinical point of care settings. Early diagnosis of skin cancer and inflammatory skin diseases are envisaged. Skin cancer will be used as a surrogate for other epithelial cancers, e.g. oral, gynaecologic or gastrointestinal cancer. Partnerships with leading innovative clinical users will enable preclinical evaluation.nThrough the use of integrated optics in combination with complementary cutting-edge technologies, BIOPSYPEN will dramatically reduce cost and size (both at least by one order of magnitude) of currently available OCT commercial systems. It will also eliminate instrumentation maintenance requirements and will reduce training and healthcare costs, paving the way to revolutionize diagnosis for general medicine and primary care.

Altri progetti dello stesso programma (FP7-ICT)

TERAFLUX (2010)

Exploiting dataflow parallelism in Teradevice Computing

Read More  

ReNaChip (2008)

Rehabilitation of a discrete sensory motor learning function by a prosthetic chip

Read More  

V-MusT.net (2011)

Virtual Museum Transnational Network

Read More